Abstract | OBJECTIVE: SUBJECTS AND METHODS: Fifteen patients (11 men, four women) with aneurysm sac expansion of 5 mm or greater after endovascular abdominal aortic aneurysm repair underwent three-phase CT, (99m)Tc-HSAD SPECT, and CT during aortography. Sensitivity calculations for three-phase CT and (99m)Tc-HSAD SPECT were performed with CT during aortography as the reference standard. The volume of each endoleak was measured with CT during aortography. Seven subjects underwent embolization with N-butyl cyanoacrylate (NBCA)- Lipiodol ( ethiodized oil, Guerbet and metallic coils. Three-phase CT and (99m)Tc-HSAD SPECT were repeated after embolization to assess their efficacy. RESULTS:
Endoleaks were interpreted as perigraft radioisotope accumulation in 12 patients (80.0%) on (99m)Tc-HSAD SPECT images, in 13 patients (86.7%) on three-phase CT images, and in 15 patients (100%) on CT during aortography. The mean endoleak volume visualized with (99m)Tc-HSAD SPECT was 8.37 cm(3) (range, 5.2-15.1 cm(3)), and the volume not visualized was 3.47 cm(3) (2.5-4.6 cm(3)), a statistically significant difference (p = 0.019). In two patients, (99m)Tc-HSAD SPECT depicted endoleaks evident at delayed phase CT during aortography but not at three-phase CT, suggesting they were slow-filling endoleaks. Accumulation of (99m)Tc-HSAD corresponding to endoleaks disappeared after embolization, but CT evaluation of embolization was impeded by artifacts of NBCA- Lipiodol and metallic coils. CONCLUSION: Technetium-99m-labeled HSAD SPECT proved less sensitive than three-phase CT but depicted endoleaks with volumes 5.2 cm(3) or greater as perigraft radioisotope accumulation. Slow-filling endoleaks can be visualized with (99m)Tc-HSAD SPECT, which can be used to evaluate the efficacy of embolization.
|
Authors | Motoki Nakai, Hirotatsu Sato, Morio Sato, Akira Ikoma, Tetsuo Sonomura, Yoshiharu Nishimura, Yoshitaka Okamura |
Journal | AJR. American journal of roentgenology
(AJR Am J Roentgenol)
Vol. 204
Issue 1
Pg. 189-96
(Jan 2015)
ISSN: 1546-3141 [Electronic] United States |
PMID | 25539256
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Radiopharmaceuticals
- Technetium Tc 99m Aggregated Albumin
- technetium Tc 99m DTPA HSA
- Technetium Tc 99m Pentetate
|
Topics |
- Aged
- Aged, 80 and over
- Aortic Aneurysm, Abdominal
(complications, diagnostic imaging, surgery)
- Endoleak
(diagnostic imaging, etiology)
- Endovascular Procedures
(adverse effects, instrumentation)
- Female
- Humans
- Male
- Middle Aged
- Radiopharmaceuticals
- Reproducibility of Results
- Sensitivity and Specificity
- Stents
(adverse effects)
- Technetium Tc 99m Aggregated Albumin
- Technetium Tc 99m Pentetate
- Tomography, Emission-Computed, Single-Photon
(methods)
- Treatment Outcome
|